Corbis-42-33807801.jpg
Reajustar

1 - 5 de 665
13 agosto 2020

Cutting-Edge micro-CT Imaging Research Shines New Light on Mooted SARS-CoV-2 Treatments

BILLERICA, Massachusetts – August 13 , 2020 – Following the recent installation of Bruker’s SkyScan 1278 in vivo micro-CT system, researchers at the KU Leuven, Belgium, have published pioneering research that provides information about the ongoing search for effective treatments against COVID-19.

10 agosto 2020

Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins

FRANKFURT, Germany--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy.

3 agosto 2020

Bruker Reports Second Quarter 2020 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2020.

30 julio 2020

Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications

JPK NanoRacer® Follows Molecular Dynamics in Real Time at 50 Frames per Second